Agenda
CCIC CONFERENCE 2019
| DAY 1 : Thursday March 21 | Day 1 - Thursday March 21 | |
| 7:30-8:30 | Breakfast | |
| 8:30-8:45 | Introductions and CCIC Update | Matthew Hill, CCIC Executive Director |
| SESSION 1: Basics and Biology of Cannabinoids and the Endocannabinoid System | ||
| Chair: Ruth Ross | ||
| 8:45-9:15 | Cannabis and its Constituents | Jonathan Page, Ph.D. |
| 9:15-9:45 | The Pharmacokinetics of Cannabis in Humans | Ryan Vandrey, Ph.D. |
| 9:45-10:15 | Introduction to the Endocannabinoid System | Matthew Hill, Ph.D. |
| 10:15-10:30 | Health and Coffee Break | |
| 10:30-11:00 | Everything you Need to Know about Cannabidiol | Cecilia Hillard, Ph.D. |
| 11:00-11:30 | Sex Differences in the Effects of Cannabis | Ziva Cooper, Ph.D. |
| Trainee Research Spotlight Award Talks | ||
| Chair: Robert Laprairie | ||
| 11:30-11:45 | Cannabinoid Hyperemesis: Investigating Mechanisms of the Aversive Effects of High Dose Cannabinoids | Marieka DeVuono, B.Sc. |
| 11:45-12:00 | Anxiety Comorbid with Colitis is Mediated by a Loss of Central Endocannabinoid Signaling | Haley Vecchiarelli, M.Sc. |
| Stakeholder Update: Federal Agencies on Research and Health | ||
| 12:00-12:15 | Cannabis Research and the CIHR: An Update | Sam Weiss, Ph.D. Scientific Director, Institute of Neurosciences, Mental Health and Addiction Canadian Institutes of Health Research |
| 12:15-12:30 | Federal Update: Canada’s Public Health Approach to the Legalization and Regulation of Cannabis | John Clare Acting Director General—Cannabis Legalization and Regulation Branch Department of Health |
| 12:30-1:30 | Lunch Break | |
| SESSION 2: Non-medical Cannabis Use and Misuse | ||
| Chair: Steve Laviolette | ||
| 1:30-2:00 | Translational Animal Models of Cannabis Use | Ryan McLaughlin, Ph.D. |
| 2:00-2:30 | Challenges in Developing a Field Sobriety Test for Cannabis | Harriet deWit, Ph.D. |
| 2:30-3:00 | Effects of Cannabis Products on Brain Structure, Cognition and Mood | Kent Hutchison, Ph.D. |
| 3:00-3:30 | Health and Coffee Break | |
| 3:30-4:00 | Cannabis Use Disorder: Current Perspectives | Margaret Haney, Ph.D. |
| 4:00-4:30 | Cannabis Use in Adolescence: Potential Interventions | Patricia Conrod, Ph.D. |
| Trainee Research Spotlight Award Talks | ||
| Chair: Robert Laprairie | ||
| 4:30-4:45 | Evaluating the Impact of Cannabis to Reduce or Manage Illicit Drug Use in Vancouver, Canada | Jenna Valleriani, Ph.D. |
| 4:45-5:00 | Cannabis Use and Chronic Pain Among People who use Drugs: Implications for Harm Reduction and Clinical Management | Stephanie Lake, M.Sc. |
| Stakeholder Update: Substance Use and Mental Health Organizations | ||
| 5:00-5:15 | Cannabis Research, Policy and Knowledge Mobilization at CCSA | Amy Porath, Ph.D. Director of Research, Canadian Centre on Substance Use and Addiction |
| 5:15-5:30 | Building the Evidence, Building Healthier Communities: Cannabis and Mental Health Research | Louise Bradley President and CEO, Mental Health Commission of Canada |
| 5:30 | Day 1 Closes | |
| DAY 2 : Friday, March 22 | ||
| 7:30-8:30 | Breakfast | |
| SESSION 3: Medical Cannabis and Therapeutic Targets | ||
| Chair: Lynda Balneaves | ||
| 8:30-9:00 | Process and Practicalities of Medical Cannabis in Canada | Danial Schechter, M.D. |
| 9:00-9:30 | Expecting the Unexpected: Managing Drug Interactions with Cannabis (and its Constituents) | Maria Zhang, Pharm.D. |
| 9:30-10:00 | Cannabinoids and Neurological Conditions | Colleen O’Connell, M.D. |
| 10:00-10:30 | Health and Coffee Break | |
| 10:30-11:00 | Cannabidiol as a Treatment for Opiate Addiction? | Yasmin Hurd, Ph.D. |
| 11:00-11:30 | The Therapeutic Potential of Cannabis for PTSD: An Update | Marcel Bonn-Miller, Ph.D. |
| Trainee Research Spotlight Award Talks | ||
| Chair: Robert LaPrairie | ||
| 11:30-11:45 | Cannabidiol as a Novel Candidate for Alcohol Use Disorder Pharmacotherapy | Jasmine Turna, Ph.D. |
| 11:45-12:00 | Cannabis and Acute Pain: A Review and Proposal of Factors that may Moderate and Mediate the Analgesic Effects of Cannabis | Michelle Thiessen, M.A. |
| 12:00-1:00 | Lunch Break | |
| SESSION 4: Harm Reduction and Public Health Implications of Cannabis Legalization | ||
| Chair: Bernard LeFoll | ||
| 1:00-1:30 | Centering the Perspectives of Cannabis Users: Insights from Qualitative Research | Rebecca Haines-Saah, Ph.D. |
| 1:30-2:00 | Race, Cannabis and the Canadian War on Drugs | Akwasi Owusu-Bempah, Ph.D. |
| 2:00-2:30 | Assessing the Use of Cannabis to Address the National Opioid Crisis | MJ Milloy, Ph.D. |
| 2:30-3:00 | Health and Coffee Break | |
| 3:00-3:30 | Cannabis and Driving | Patricia DiCiano, Ph.D. |
| 3:30-4:00 | Cannabis Advertising | David Hammond, Ph.D. |
| 4:00-5:00 | Stakeholders Panel: Perspectives on Legalization and Research | • Hanan Abramovici, PhD (Health Canada) • Shelita Dattani, PharmD (CPhA) • Bernard Le Doll MD/PhD (CAMH) • Kira London-Nadeau (CSSDP) • Josette Roussel RN, MSc, MEd (CNA) |
| 5:00 | Congress Closes |